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Abstract 
Inflammasomes are immune complexes, which induce an inflammatory response 
upon sensing of different stress signals. This effect is mainly mediated by activation 
and secretion of the proinflammatory cytokines prointerleukin(IL)-1β and -18. Here 
we report that infection of human primary keratinocytes with the double-stranded (ds) 
DNA viruses Modified Vaccinia Virus Ankara (MVA) or Herpes Simplex Virus Type 1 
(HSV-1) induced secretion of mature IL-1β and -18. This secretion was dependent on 
several inflammasome complexes, however, the AIM2 inflammasome, which is 
activated by binding of dsDNA, played the most important role. Whereas 
prestimulation of keratinocytes with interferon (IFN)-γ moderately increased MVA-
induced IL-1β and IL-18 secretion, it was essential for substantial secretion of these 
cytokines in response to HSV-1 infection. IFN-γ partially restored HSV-1-suppressed 
proIL-1β expression and was also required for inflammasome activation. Most 
importantly, IFN-γ strongly suppressed virus replication in keratinocytes in vitro and 
ex vivo, which was independent of inflammasome activation. Our results suggest 
that, similar to herpesviridae infection in mice, HSV-1 replication in human skin is 
controlled by a positive feedback loop of keratinocyte-derived IL-1/IL-18 and IFN-γ 
expressed by immune cells. 
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Introduction 
Innate immunity is based on germline-encoded receptors, which detect pathogen- 
and danger-associated molecular patterns (PAMPs and DAMPs). Upon receptor 
activation, these exogenous and endogenous stress factors induce an inflammatory 
response, which is required for efficient host defense against pathogens and rapid 
repair after tissue damage. Inflammasomes comprise a group of cytoplasmic or 
nuclear complexes, consisting of a central sensor protein such as NACHT, LRR and 
PYD domains-containing protein 3 (NLRP3), NLR family CARD domain-containing 
protein 4 (NLRC4), absent in melanoma 2 (AIM2) or γ-interferon-inducible protein 16 
(IFI16), the adaptor apoptosis-associated speck-like protein containing a CARD 
(ASC), and the effector caspase-1 (Bauernfeind and Hornung, 2013; Schroder and 
Tschopp, 2010; Strowig et al., 2012). Whereas AIM2 and IFI16 directly bind 
pathogen-derived DNA and subsequently recruit ASC and caspase-1, the molecular 
mechanisms underlying detection of DAMPs and PAMPs by other types of 
inflammasomes are less well understood (Bauernfeind and Hornung, 2013; Dowling 
and O'Neill, 2012). Upon assembly of inflammasomes, the protease caspase-1 is 
activated, cleaves and thereby activates the proinflammatory cytokines pro-
interleukin(IL)-1β and -18, which induce an inflammatory response after secretion. 
Inflammation is supported by a lytic and caspase-1-dependent form of cell death 
termed pyroptosis and by other less well characterized mechanisms (Miao et al., 
2011; Sollberger et al., 2014). In macrophages and dendritic cells, where 
inflammasomes have mainly been characterized, IL-1β secretion and inflammasome 
activation requires a priming step, which induces expression of proIL-1β, NLRP3 and 
AIM2 (Gross et al., 2011; Hornung and Latz, 2010). However it is not clear, whether 
activation of the AIM2 inflammasome in human primary keratinocytes requires 
priming (Dombrowski et al., 2011; Kopfnagel et al., 2011), whereas priming is 
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dispensable for UVB-induced NLRP3 inflammasome activation (Feldmeyer et al., 
2007).  
HSV-1 belongs to the family of Herpesviridae, which consists of enveloped viruses 
with a linear dsDNA genome (Grunewald et al., 2003; van Hal and Dwyer, 2009). It is 
further classified into the subfamily of the Alphaherpesvirinae, whose members are 
characterized by short replication cycles, destruction of the host cell, and the ability to 
establish lifelong latency in sensory neurons innervating peripheral tissues (Egan et 
al., 2013; van Hal and Dwyer, 2009; Whitley, 2011). To do so, HSV-1 must be able to 
evade the innate immune system, demonstrating its efficient adaptation to humans, 
which is also reflected in the high seroprevalence of 70% to 80% in the population of 
developing countries (Chayavichitsilp et al., 2009; Paludan et al., 2011; Whitley and 
Roizman, 2009). 
Although HSV-1 infections usually do not cause much harm, they can cause 
significant morbidity and mortality in immunocompromised individuals by 
generalization of the infection and brain involvement. Infections usually start at 
mucocutaneous parts of the skin by targeting keratinocytes (Ellermann-Eriksen, 
2005; Paludan et al., 2011).  
Productive HSV infection in epithelial cells can be divided into different steps. First, 
the virion binds to receptors on the surface of the host cell and induces membrane 
fusion. Viral capsid and tegument proteins such as VP16, which is involved in 
immediate-early gene transcription, are released into the host cell cytoplasm. Upon 
transport of the capsid to the nucleus, viral DNA is released into the nucleus. After 
transcription and translation of viral immediate-early (IE, α) and early (E, β) genes, 
viral DNA replication is initiated. The early DNA-binding infected cell protein 8 (ICP8) 
is involved in this process and stimulates late gene transcription. Then transcription 
and translation of viral late (L, γ) genes coding for capsid and tegument proteins is 
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induced resulting in assembly of viral DNA with the capsid. Finally, newly generated 
virions are released from the host cell (Taylor et al., 2002). 
For an efficient antiviral response, cells must recognize the virus, which is achieved 
by innate immune receptors of the Toll-like receptor (TLR) family, and mount an 
immune response. Genomic DNA is most likely the main trigger of HSV-induced 
innate immune responses (Paludan et al., 2011). 
HSV-1 activates the NLRP3 inflammasome in THP-1 cells (Muruve et al., 2008) and 
the IFI16 and NLRP3 inflammasomes in fibroblasts (Johnson et al., 2013); Kaposi 
sarcoma-associated herpesvirus (KSHV) activates the IFI16 inflammasome in 
endothelial cells (Kerur et al., 2011), and mouse cytomegalovirus (mCMV) the AIM2 
inflammasome in macrophages (Rathinam et al., 2010). Interestingly, the amounts of 
detected mature IL-1β and IL-18 were extremely low or even undetectable in virus-
infected cells (Johnson et al., 2013; Kerur et al., 2011; Milora et al., 2014). For HSV-1 
and varicella-zoster virus (VZV), active immune evasion by targeting of different 
proteins, which are required for the production of IL-1/-18 activity, has been 
described (Black et al., 2009; Johnson et al., 2013; Miettinen et al., 2012). 
Interestingly, IL-1α, which signals through the same receptor as IL-1β, acts as 
alarmin in HSV-1 infection. IL-1 activity reduces mortality in mice caused by HSV-1, 
which is most likely mediated by IL-1α, as keratinocytes do not secrete IL-1β upon 
HSV-1 infection (Milora et al., 2014). Also other viruses such as poxvirus are able to 
suppress the production, activation, or activity of IL-1β and -18 (Gram et al., 2012; 
Lamkanfi and Dixit, 2011; Taxman et al., 2010; Zimmerling et al., 2013).  
Since epithelial cells are the major target cell type during primary and recurrent HSV 
infection, we addressed, whether HSV-1 activates inflammasome complexes in 
human primary keratinocytes. In this study, we found that HSV-1 as well as dsDNA or 
the dsDNA virus MVA induced maturation of proIL-1β/-18 in human primary 
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keratinocytes, which required expression of proteins of the NLRP3 and AIM2 
inflammasomes. However, HSV-1 negatively regulated expression and activation of 
proIL-1/18 at different levels, which was counterbalanced by IFN-γ stimulation of 
keratinocytes. In addition, IFN-γ strongly reduced HSV-1 replication in human primary 
keratinocytes and in human epidermis ex vivo. Our results suggest that keratinocyte-
derived IL-1β or/and IL-18 and IFN-γ expressed by T cells or other cells form a 
feedback loop important for the control of HSV-1 infections in the skin. 
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Results 
Priming increases DNA-induced AIM2- and NLRP3-dependent IL-1β secretion 
by keratinocytes 
It has recently been demonstrated that transfection of human primary keratinocytes 
with DNA induces secretion of IL-1β  dependent on AIM2 expression (Dombrowski et 
al., 2011; Kopfnagel et al., 2011). However, whether this DNA-induced IL-1β 
secretion requires priming with IFN-γ and TNF-α is a matter of debate (Dombrowski 
et al., 2012). 
In our hands, transfection of human primary keratinocytes with poly(dA:dT) induced 
secretion of significant amounts of IL-1β as detected by ELISA (Figure 1a), and this 
was reproducibly observed with cells from different donors (not shown). 
Prestimulation with TNF-α and IFN-γ further increased the levels of IL-1β in 
supernatants (Figure 1a). Western blotting confirmed the presence of mature IL-1β in 
supernatants of these cells as well as of processed IL-18 (Figure 1b). In addition, 
IFN-γ/TNF-α stimulation of keratinocytes induced proIL-1β expression, which most 
likely contributed to increased amounts of processed and secreted IL-1β.  
To confirm that DNA-induced inflammasome activation of keratinocytes depends on 
AIM2 expression (Dombrowski et al., 2011), we performed siRNA-mediated knock-
down experiments in primary keratinocytes (Figure 1c). We already demonstrated 
that siRNA-mediated suppression of inflammasome protein expression is efficient in 
keratinocytes (Feldmeyer et al., 2007; Keller et al., 2008; Sollberger et al., 2012). As 
expected, a knock-down of AIM2 and caspase-1 expression significantly reduced the 
secretion of mature IL-1β and -18, suggesting that the AIM2 inflammasome is 
responsible for DNA-induced caspase-1 activation (Figure 1c). Surprisingly, a knock-
down of NLRP3 expression also strongly reduced proIL-1β and -18 processing, 
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whereas siRNA which targets the unrelated VEGF-A, did not influence cytokine 
processing. 
These experiments demonstrate that in human primary keratinocytes the AIM2 and 
NLRP3 inflammasomes are required for efficient caspase-1 activation and 
subsequent processing of proIL-1β and -18 induced by cytoplasmic DNA. Although 
priming with TNF-α and IFN-γ increases cytokine maturation, it is not essential. 
IFN-γ significantly enhances AIM2-dependent proIL-1β/-18 maturation induced 
by MVA  
MVA, a highly attenuated vaccinia virus generated by extensive passaging in tissue 
culture from a smallpox vaccine strain (Mayr et al., 1975), is used as a vaccine vector 
against different infections. The MVA strains MVA-BN and MVA-BN-GFP used in this 
study are able to transduce human cells but unable to replicate in these cells (Suter 
et al., 2009). Recently, it has been demonstrated that MVA activates the NLRP3 
inflammasome in THP-1 cells upon infection (Delaloye et al., 2009). Infection of 
human primary keratinocytes with MVA induced secretion of IL-1β and consequently 
inflammasome activation (Figure 2a and b). Prestimulation of keratinocytes with IFN-
γ for 24 h resulted in a significant increase in mature IL-1β in the supernatant (Figure 
2a, b, and d). Since it is well known that IFNs play important roles in the defense 
against viruses, we analyzed the infection rate of keratinocytes with a GFP-encoding 
MVA upon prestimulation with IFN-α, -β, and -γ (Figure 2c). IFN-γ had the strongest 
inhibitory effect on MVA infection of keratinocytes. In contrast to IFN-γ, type I IFNs 
reduced proIL-1β and -18 maturation in MVA-infected keratinocytes (Figure 2d), and 
a role of type I IFNs in the inhibition of proIL-1β production has been described 
earlier (Guarda et al., 2011). These experiments suggest that inflammasome 
activation by MVA in keratinocytes is not correlated with the rate of MVA infection. To 
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identify the type of inflammasome complexes that sense MVA infection of 
keratinocytes, we knocked down the expression of several inflammasome proteins 
(Figure 2e). Suppression of expression of caspase-1 and ASC, which are 
components of all inflammasome complexes, strongly inhibited IL-1β and -18 
secretion. Surprisingly, a knock-down of NLRP3 expression, which is required for 
MVA-induced proIL-1β maturation in THP-1 cells (Delaloye et al., 2009), only slightly 
reduced secretion of IL-1β by keratinocytes. Although it is difficult to compare the 
effect of knock-down of different genes, we found a strong dependency of UVB-
induced inflammasome activation on NLRP3 expression (Feldmeyer et al., 2007). In 
agreement with the fact that MVA is a double-stranded DNA virus, a knock-down of 
AIM2 expression almost completely abolished MVA-induced IL-1β/-18 secretion by 
keratinocytes (Figure 2e). In addition, IFI16, but not NLRC4 expression contributed to 
MVA-induced caspase-1 activation in keratinocytes (Figure 2e). The knockdown 
efficiencies were assessed by qPCR and show strong reduction of gene expression 
upon siRNA transfection (Figure S1). To address how NLRP3 might be activated in 
this context (Kawamura et al., 2014), we performed experiments with the antioxidant 
PDTC, the calcium chelator BAPTA and its cell permeable version BAPTA-AM, and 
the NLRP3 inhibitor glybenclamide (Figure 2f). Upon MVA infection, we observed 
reduced secretion of IL-1β and IL-18 from cells treated with PDTC, BAPTA-AM and 
glybenclamide, suggesting an involvement of ROS, intracellular Ca2+ levels, and K+ 
efflux in inflammasome activation. Since keratinocytes release mature IL-1β/-18 upon 
MVA infection, it is tempting to speculate that these cytokines might act in an auto- or 
paracrine manner on the keratinocytes to protect them from infection. However, such 
an effect could not be observed in IL-1β/-18-pretreated keratinocytes (Figure 2g). In 
summary, MVA infection of keratinocytes resulted in activation of the AIM2 
inflammasome, but also expression of NLRP3 and IFI16 supported cytokine 
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maturation. Prestimulation of keratinocytes with IFN-γ strongly increased IL-1β/-18 
secretion upon MVA infection and reduced the infection rate.  
HSV-1 infection activates the AIM2 and NLRP3 inflammasomes in IFN-γ-
stimulated human primary keratinocytes 
Previous studies demonstrated that HSV-1 infection of keratinocytes does not induce 
secretion of active IL-1β, although several publications demonstrate inflammasome 
activation by HSV-1 in other cell types (Johnson et al., 2013; Kerur et al., 2011; 
Milora et al., 2014). To address this issue, we infected IFN-γ-primed human primary 
keratinocytes with increasing amounts of HSV-1 and analyzed secretion of IL-1β by 
ELISA and Western blotting (Figure 3a). Surprisingly, we clearly detected IL-1β 
production upon HSV-1 infection in a dose-dependent manner. However, the 
amounts of IL-1β were lower than those observed upon poly(dA:dT) transfection or 
MVA infection (Figure 1 and 2). This was most likely due to inflammasome-
dependent caspase-1 activation, since we also detected processing of the caspase-1 
substrate proIL-18 upon HSV-1 infection (Figure 3a). HSV-1 infection of keratinocytes 
induced IL-1β production after 72 h (Figure 3b). At this time point the cells detached 
from the surface of the culture dish and we detected significant amounts of β-actin in 
the supernatant, reflecting cell lysis (results not shown and Figure 3b). In order to 
examine, whether HSV-1 did indeed activate inflammasome complexes we 
performed experiments in keratinocytes with siRNA-mediated knock-downs of gene 
expression (Figure 3c). As expected, expression of caspase-1 and ASC were 
required for IL-1β and -18 secretion. In addition, a knock-down of AIM2, NLRP3, and 
IFI-16 expression strongly reduced the maturation of these cytokines, demonstrating 
that several types of inflammasomes detect HSV-1 in human primary keratinocytes. 
However, inflammasome activation and secretion of IL-1β and -18 did not influence 
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HSV-1 infection and replication, since we detected the same amounts of viral DNA in 
infected control keratinocytes and in cells with reduced expression of these critical 
inflammasome proteins (Figure 3d). These experiments demonstrate that HSV-1 
infection induces activation of several types of inflammasomes; however, this results 
in secretion of only low amounts of IL-1β and -18. Inflammasome activation does not 
influence HSV-1 replication. 
IFN-γ counteracts HSV-1-induced suppression of proIL-1β expression and 
prevents virus replication 
Since IFN-γ prestimulation of keratinocytes strongly enhanced MVA-induced IL-1β 
and -18 secretion (Figure 2d), we addressed the question whether IFN-γ primes 
keratinocytes for HSV-1-induced inflammasome activation. Whereas mock-treated 
cells secreted only very low amounts of IL-1β and -18 upon infection with HSV-1, 
IFN-γ priming strongly enhanced the secretion of these cytokines (Figure 4a). In 
contrast, IFN-α and -β reduced the amount of IL-1β and -18 in the supernatant of 
HSV-1-infected keratinocytes. All three IFNs reduced HSV-1 replication in 
keratinocytes, but IFN-γ had clearly the strongest effect (Figure 4b). This effect of 
IFN-γ was dose-dependent (Figure 4c) and was only detected if the cytokine was 
added more than 24 h before infection (Figure 4d). To assess whether IFN-γ reduces 
the expression of HSV-1 entry receptors or co-receptors and thereby affects viral 
infection, we performed qPCR after IFN-γ priming for nectin (PVRL)-1 and -2, herpes 
virus entry mediator (HVEM, TNFRSF), myosin 9 (MYH9), paired immunoglobin-like 
type 2 receptor alpha (PILRα), macrophage receptor MARCO, and AIM2 as a 
positive control (Figure 4e). Expression of mRNA of these proteins was either not 
affected by IFN-γ treatment or even induced, suggesting that IFN-γ does not limit 
virus production in keratinocytes through downregulation of entry receptor 
expression. 
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To further determine the physiological relevance of our findings, we tried to infect 
keratinocytes ex vivo in human skin with HSV-1 (Figure 4f, S1b). Human skin was 
sewed on a culture dish with medium in contact with the lower part and with the outer 
surface exposed to the air. Then, we generated a full-thickness cut through epidermis 
and part of the dermis and HSV-1 was applied to this cut. Keratinocytes, but not cells 
in the dermis, were infected by HSV-1 as revealed by expression of the HSV-1-
specific proteins VP16 and ICP8 (Figure 4f, S1b). Most importantly, pretreatment of 
the skin with IFN-γ by topical application strongly reduced the number of HSV-1-
infected keratinocytes, as revealed by staining for VP16 and ICP8.  
To address the question how IFN-γ primes keratinocytes for IL-1β and IL-18 
production, we analyzed the mRNA levels of inflammasome proteins and cytokines in 
keratinocytes upon HSV-1 infection with and without prestimulation with IFN-γ (Figure 
5a, S1c). As expected, IFN-γ induced mRNA levels of inflammasome proteins 
(particularly AIM2) as well as the expression of proIL-1β, but not of proIL-18 and IFN-
β. Surprisingly, HSV-1 infection of keratinocytes had a similar effect on mRNA 
expression of inflammasome proteins, since the expression of all genes that we 
analyzed was induced, except expression of proIL-1β and -18, which were down-
regulated (Figure 5a). IFN-γ stimulation of keratinocytes before infection with HSV-1 
increased mRNA levels of several inflammasome proteins compared to infected cells 
without priming, but could not rescue the HSV-1-mediated suppression of proIL-1β 
and -18 mRNA levels. This result suggests that priming of HSV-1-infected human 
keratinocytes with IFN-γ does not involve transcriptional regulation of proIL-1β and -
18. Western blots revealed that stimulation of keratinocytes with IFN-γ induced 
protein expression of caspase-1, caspase-4, NLRP3 and proIL-1β (Figure 5b). 
However, only proIL-1β protein expression was reduced in keratinocytes upon 
infection with HSV-1 and this reduction was partially rescued by IFN-γ priming. 
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To address the question whether HSV-1 replication is required for suppression of 
proIL-1β production, we infected keratinocytes with a replication-deficient HSV-1 
(rHSV-1 5dl1.2), which lacks the viral transcription regulator ICP27 (Figure 5c; 
(McCarthy et al., 1989). Keratinocytes infected with rHSV-1 5dl1.2 produced the 
same amount of proIL-1β as non-infected control cells, whereas infection with wild 
type (wt) HSV-1 reduced proIL-1β protein expression. Consequently, infection of 
keratinocytes with rHSV-1 5dl1.2 resulted in significantly more secretion of mature IL-
1β as infection with wt virus. 
Inflammasome activation and secretion of mature IL-1β and IL-18 were also blocked 
when keratinocytes were treated with other NLRP3 activators such as UVB 
irradiation, nigericin, or cycloheximide (Figure 5d). Stimulation with IFN-γ prevented 
the inhibitory effect of HSV-1 infection. However, neither did IL-1β and IL-18 inhibit 
HSV-1 replication directly (Figure 5e) nor did HSV-1 infection induce IFN-γ secretion 
by keratinocytes (results not shown).  
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Discussion 
Here we report that IFN-γ-primed human primary keratinocytes secrete active IL-1β 
and IL-18 upon HSV-1 infection. Although keratinocytes are infected by HSV-1 at 
mucocutaneous sites in vivo and represent the virus’ primary target, most reports 
dealing with HSV-1 infection are based on other cell types. In keratinocytes, HSV-1-
induced proIL-1β and -18 maturation depends on the inflammasome proteins AIM2, 
IFI16, and NLRP3. In contrast, in THP-1 cells expression of NLRP3 is needed for 
caspase-1 activation, and in fibroblasts IFI16 and NLRP3 are required (Johnson et 
al., 2013; Muruve et al., 2008). AIM2 is also the most important sensor for MVA-
induced caspase-1 activation in keratinocytes, whereas NLRP3 plays the key role in 
THP1 cells (Delaloye et al., 2009). This suggests that different types of 
inflammasome complexes sense the same pathogen in different cell types and that 
several of these complexes are involved in MVA and HSV-1 detection in 
keratinocytes.  
Compared with MVA, HSV-1 infection of keratinocytes induces secretion of 
significantly less IL-1β and -18. Interestingly, it has been recently reported that 
keratinocytes are not able to secrete IL-1β upon HSV-1 infection (Milora et al., 2014). 
In addition, other reports dealing with inflammasome activation caused by HSV-1 
infection or related herpesviridae demonstrate a very low or even undetectable 
amount of secreted mature IL-1β (Johnson et al., 2013; Kerur et al., 2011; Milora et 
al., 2014). These results suggest that HSV-1 is either a weak inflammasome activator 
or actively suppresses the production of IL-1β. In line with the ability of HSV-1 to 
infect sensory neurons in a latent manner, several immune evasion mechanisms 
have been demonstrated for herpesviridae (Paludan et al., 2011), including the 
inhibition of the production of IL-1 and IL-18 (Black et al., 2009; Johnson et al., 2013; 
Miettinen et al., 2012). Our results suggest that HSV-1 suppresses IL-1β production 
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at the posttranscriptional level through a reduction of protein expression of the 
cytokine proform on the one hand and through inhibition of inflammasome activation 
on the other hand. Interestingly, the HSV-1 immediate early gene ICP0 encodes an 
E3 ubiquitin ligase, which is known to counteract immunity (Lanfranca et al., 2014) 
and to inhibit IFI16/NLRP3 inflammasome activation (Johnson et al., 2013). This 
raises the possibility that ICP0 is also involved in antagonizing IL-1β/IL-18 production 
in keratinocytes. 
Whereas a function of type I IFNs in antiviral defense is well documented (Stetson 
and Medzhitov, 2006), our results suggest a particularly important role of IFN-γ in 
HSV-1-infected human keratinocytes and in human epidermis ex vivo. Prestimulation 
of keratinocytes with IFN-γ is required for inflammasome activation and secretion of 
mature IL-1β and -18. In contrast, IFN-α and particularly IFN-β rather inhibit IL-1β 
production.. Most likely, IFN-γ exerts a general positive priming effect on 
inflammasome activation in different cell types, which is particularly important for 
AIM2 expression and therefore AIM2 inflammasome activation. However, comparison 
of poly(dA:dT)-, MVA-, and HSV-1-induced IL-1β and IL-18 production in 
keratinocytes reveals a prominent role of IFN-γ for HSV-1-induced inflammasome 
activation. This is partially due to the fact that HSV-1 replication suppresses proIL-1β 
protein expression, which is antagonized by IFN-γ. Most importantly, IFN-γ strongly 
suppresses virus replication in keratinocytes. However, inflammasome activation is 
not linked to HSV-1 replication in keratinocytes in vitro. 
Recently, it has been reported that IFN-γ inhibits HSV-1 replication in vitro and is also 
required for the efficient early control of HSV and Herpesviridae replication in vivo 
(Ellermann-Eriksen, 2005; Kim et al., 2013; Rathinam et al., 2010). In IL-18R 
deficient mice, IFN-γ expression is strongly reduced after infection with the 
herpesvirus mouse cytomegalovirus (mCMV) (Pien and Biron, 2000). This 
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demonstrates that IFN-γ expression is at least in part dependent on IL-18 (Ellermann-
Eriksen, 2005; Fujioka et al., 1999). In addition to the caspase-1 substrate proIL-18, 
an important role in defense against HSV was also described for IL-1β (Saha et al., 
2010; Sergerie et al., 2007), and IL-1 could be detected in herpetic lesions and 
keratinocytes of HSV-1-infected human skin (Mikloska et al., 1998). In contrast, MVA 
induces IL-1β activation, but has been shown to alleviate IL-1 activity by expression 
of a soluble IL-1β receptor (vIL-1βR), which scavenges free active IL-1β. Infection of 
mice with MVA deleted for the gene encoding vIL-1βR show higher levels of IFN-γ-
secreting activated memory CD8+ T cells compared to mice infected with wild type 
MVA (Zimmerling et al., 2013). Interestingly, it has been recently reported that tissue-
resident memory CD8+ T cells play an important role in the control of reinfection by 
HSV-1 through induction of an antiviral state in keratinocytes, most likely mediated by 
IFN-γ secretion (Ariotti et al., 2014). This IFN-γ secretion may be induced by 
keratinocytes, as the T cell response is dependent on viral antigen presentation 
through infected epithelial cells (Macleod et al., 2014). We speculate that IFN-γ is 
mostly derived from T cells, since it is published that cells expressing the natural killer 
cell marker CD56 can hardly be detected in herpetic lesions, whereas most infiltrating 
cells are positive for CD3 (Morizane et al., 2005). Then, IFN-γ-stimulated 
keratinocytes are able to activate caspase-1 upon HSV-1 infection and in turn secrete 
IL-1 and IL-18. The cytokines directly or indirectly further enhance expression and 
secretion of IFN-γ, resulting in a positive feedback loop. Such a feedback loop has 
also been described in mice to be important for control of mCMV infection (Rathinam 
et al., 2010). Most importantly, IFN-γ not only enhances IL-1β and IL-18 production, 
but also suppresses virus replication in keratinocytes, thereby controlling and limiting 
virus spread in the epidermis. 
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In conclusion, our results suggest that IFN-γ may be useful for the treatment of HSV-
1 infections in immunocompromised individuals through the induction of IL-1β/IL-18 
production and inhibition of virus replication in keratinocytes. 
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Materials and Methods 
 
Viruses 
Wild type MVA-BN and GFP-encoding MVA-mBNbc37#2 were gifts from Bavarian 
Nordic GmbH (Martinsried, Germany). Vero cells, Vero 2-2 cells (Smith et al., 1992), 
wild type HSV-1 (F strain), and rHSV-1 5dl1.2 (McCarthy et al., 1989) were gifts from 
the group of Prof. Dr. C. Fraefel (Zurich, Switzerland).  
 
Cell culture  
Isolation and culture of human primary foreskin keratinocytes (HFK) has been 
described (Feldmeyer et al., 2007; Keller et al., 2008; Sollberger et al., 2012). Briefly, 
HFK were passaged in keratinocyte-SFM (K-SFM, GIBCO BRL, Paisley, Scotland), 
supplemented with EGF and BPE (GIBCO BRL, Paisley, Scotland). Cells were 
seeded for experiments in passage 3. For siRNA-mediated knock down experiments, 
cells were seeded in 6-well plates at a density of 1x105 cells/well. The day after 
seeding, cells were transfected with siRNA oligonucleotides (10 nM) using 2 µl 
INTERFERin (Polyplus, Illkirch, France) transfection reagent and left for 48 h before 
treatment. 
 
Human biopsies 
Human biopsies were collected with informed written consent upon approval from 
Local Ethical Committees and were conducted according to the Declaration of 
Helsinki Principles. 
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Figure Legends 
Figure 1 Cytoplasmic DNA activates the AIM2 and NLRP3 inflammasomes in 
human primary keratinocytes. 
(a and b) Human primary keratinocytes were stimulated with IFN-γ (100 ng/ml), TNF-
α (10 ng/ml) or mock-treated and 24 h later transfected with poly(dA:dT) (4 µg/ml). 
Supernatants and cells were harvested after 24 h and analyzed for secretion of IL-1β 
by ELISA and for cell lysis by lactate dehydrogenase (LDH) assay (a) or analyzed for 
secretion and expression of the indicated proteins by Western blot (b). (c) Human 
primary keratinocytes were transfected with siRNA as indicated (scrambled siRNA 
served as control) and three days later transfected with poly(dA:dT) (4 µg/ml). After 
24 h supernatants and cells were harvested and analyzed for IL-1β in the 
supernatant by ELISA or for expression and secretion of the indicated proteins by 
Western blot.  
Statistics: (a, c) Error bars represent the mean ± SD of a representative experiment 
performed in triplicates. 1-way ANOVA with Dunnett’s multiple comparison test 
comparing all values to the mock-treated control (a, right bar) or scr (c) was 
performed. ** p ≤ 0.01 *** p ≤ 0.001. 
 
Figure 2 MVA induces AIM2 inflammasome activation in keratinocytes. 
(a and b) Human primary keratinocytes were mock-treated or stimulated with IFN-γ 
(20 ng/ml). 24 h later cells were infected with MVA using different MOIs and 
supernatants were harvested after additional 48 h (a) or infected with MVA (MOI=2) 
and harvested at the indicated time points (b). IL-1β was determined by ELISA (a, b, 
and d). Keratinocytes were left untreated or treated with IFN-α (1’000 U/ml), IFN-β 
(1’000 U/ml), or IFN-γ (20 ng/ml) (c, d) or with the indicated concentrations of IL-1β or 
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IL-18 (g) for 24 h and infected with a GFP-encoding MVA (c, g) or with MVA (d) 
(MOI=10). The percentage of GFP-expressing keratinocytes was determined 24 h 
later by flow cytometry (c, g). (d) Supernatants and cells were harvested 48 h after 
infection and analyzed for secretion of IL-1β by ELISA and cell lysis by LDH assay. 
Expression and secretion of the indicated proteins was determined by Western blot. 
(e) Keratinocytes were transfected with siRNA as indicated (scrambled siRNA served 
as control). 48 h after siRNA transfection cells were treated with IFN-γ (20 ng/ml). 48 
h post infection with MVA (MOI=10) or mock-treatment, supernatants and cells were 
harvested and analyzed for the secretion and expression of the indicated proteins by 
Western blot. (f) Keratinocytes were treated with IFN-γ (20 ng/ml) for 24 h before 
mock-treatment or treatment with DMSO (3 µl/ml), PDTC (500 µM), BAPTA-AM (12.5 
µM), BAPTA (25 µM), or glybenclamide (120 µM). Cells were infected with MVA 
(MOI=10) 1 h later. Cells and supernatants were harvested 48 h post infection and 
analyzed for expression and secretion of the indicated proteins by Western blot. The 
asterisk marks the relevant band for mature IL-1β.  
Statistics: (a, b, d) Error bars represent the mean ± SD of a representative 
experiment performed in triplicates. Unpaired t-test comparing +IFN-γ and -IFN-γ (a, 
b) or 1-way ANOVA with Bonferroni’s multiple comparison test comparing all values 
(d) was performed. ** p ≤ 0.01 *** p ≤ 0.001 **** p ≤ 0.0001. 
 
Figure 3 HSV-1 infection of keratinocytes activates different types of 
inflammasomes. 
(a and b) Human primary keratinocytes were treated with IFN-γ (20 ng/ml) for 24 h, 
infected with different MOIs of HSV-1 or mock-treated as indicated and harvested 
after 72 h (a) or infected (MOI=5) and harvested at different time points as indicated 
(b). The asterisk marks the relevant band for mature IL-1β (a). IL-1β in the 
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supernatant was determined by ELISA. The expression and secretion of the indicated 
proteins was analyzed by Western blot (c and d). (c and d) Keratinocytes were 
transfected with the respective siRNAs (scrambled siRNA served as control) and 24 
h later treated with IFN-γ (20 ng/ml). (c) After 24 h the cells were infected with HSV-1 
(MOI=10), cells and supernatants were harvested 48 h later and analyzed for the 
secretion and expression of the indicated proteins by Western blot. (d) Keratinocytes 
were treated as described for (c) and infected with HSV-1 (MOI=0.5). Viral replication 
was quantified by quantitative PCR. 
Statistics: (a, b) Error bars represent the mean ± SD of a representative experiment 
performed in triplicates. 1-way ANOVA with Dunnett’s multiple comparison test 
comparing all values to MOI=0 (a) or 6 h (b) was performed. * p ≤ 0.05 ** p ≤ 0.01 *** 
p ≤ 0.001. 
 
Figure 4 IFN-γ is required for HSV-1-induced IL-1β secretion and inhibits virus 
replication. 
(a and b) Keratinocytes were left untreated or treated with IFN-α (1’000 U/ml), IFN-β 
(1’000 U/ml) or IFN-γ (20 ng/ml) and 24 h later infected with HSV-1 (a: MOI=1, b: 
MOI=0.5). (a) Cells and supernatants were harvested after 72 h and analyzed for 
secretion of IL-1β by ELISA and expression and secretion of the indicated proteins by 
Western blot. (b) Viral replication was quantified by qPCR 48 h after infection. (c and 
d) Keratinocytes were treated with IFN-γ as indicated (c) or with 20 ng/ml (d), either 
24 h (c) or at different time points (d) before infection with HSV-1 (MOI=1). Western 
blots were performed for analysis of expression/activation of the indicated proteins. 
(e) Keratinocytes were treated with 20 ng/ml IFN-γ or mock-treated for 24 h. mRNA 
levels of the indicated genes were determined by qRT-PCR. (f) Human skin was cut 
with a scalpel ex vivo and 6.6 x 106 pfu HSV-1 were added with or without prior IFN-γ 
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priming (300 ng applied on cut) for 24 h. After 5 d, the skin was fixed and paraffin 
sections were stained with hematoxylin and an antibody against VP16, ICP8, or an 
isotype control. Scale bars correspond to 300 µm.  
Statistics: (a, b) Error bars represent the mean ± SD of a representative experiment 
performed in triplicates. 1-way ANOVA with Dunnett’s multiple comparison test 
comparing all values to MOI=0 (a) or 6 h (b) was performed. * p ≤ 0.05 ** p ≤ 0.01 *** 
p ≤ 0.001. 
 
Figure 5 HSV-1 inhibits and IFN-γ enhances production of IL-1β. 
(a-d) Keratinocytes were mock-treated or treated with IFN-γ (20 ng/ml) and 24 h later 
infected with HSV-1 (MOI=0.5 (a and b) and 1 (c and d)) where indicated, replication-
deficient HSV-1 rHSV-1 5dl1.2 (c) or mock-treated. (a) mRNA levels of the indicated 
genes were determined after 48 h by qRT-PCR and are shown in relation to the 
levels before infection. (b-d) Western blots for detection of the expression/activation 
of the indicated proteins. (b) Cell lysates were harvested 24 h post infection. (c) 
Lysates and supernatants were harvested 72 h post infection. (d) HSV-1-infected or 
mock-treated keratinocytes were irradiated after medium change with UVB (86.4 
mJ/cm2) or treated with nigericin (5 µM) or cycloheximide (CHX; 5 µg/ml). Lysates 
and supernatants were harvested 24 h later. (e) Keratinocytes were mock-treated or 
treated with the indicated concentrations of IL-1β or IL-18 for 24 h and infected with 
HSV-1 (MOI=1). Viral replication was quantified by qPCR 24 h after infection. 
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